Core Viewpoint - Aishalon announced an investment of up to €20 million to enhance its overseas market strategy, specifically in Morocco, to accelerate the construction of an innovative medical production base [1] Group 1: Investment Details - The company plans to use its own and self-raised funds for the investment through its Hong Kong subsidiary, EXCELLENT MEDICAL TECHNOLOGY CO., LIMITED [1] - The investment will primarily be allocated to sign a construction contract with local companies CRBC TANGER LIMITED and Lecons Group SARL for the first phase of the factory construction in Tangier Technology City [1] - The total contract amount for the construction project is 151.75 million Moroccan Dirhams, approximately €14.1 million [1] Group 2: Management Authorization - The company's board has authorized the management to handle specific matters related to this external investment, including negotiations, signing legal documents, and obtaining necessary approvals [1]
爱舍伦（920050）：拟向摩洛哥孙公司增加1500万欧元投资额